← Open Payments lookup

MELINDA BAEHR: Open Payments

NPI 1114344157 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$393 in 17 payments from 7 companies in 2025. Trend: 2023 $33 · 2024 $149 · 2025 $393

Food & beverage: $393
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.4$89
Alkermes, Inc.3$76
Janssen Pharmaceuticals, Inc3$68
Neurocrine BioSciences, Inc.2$57
E.R. Squibb & Sons, L.L.C.3$55
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$29
Teva Pharmaceuticals USA, Inc.1$18

Products named: ARISTADA, ABILIFY ASIMTUFII, INVEGA SUSTENNA, INGREZZA, COBENFY, CAPLYTA, ABILIFY MAINTENA, UZEDY.

Industry payments across AZ — which companies pay providers there.